Satralizumab is a prescription medicine used to treat Neuromyelitis Optica Spectrum Disorder (NMOSD), a condition that affects the optic nerves and spinal cord.
| Drug class | IL-6 Receptor Inhibitor |
|---|---|
| Type | Single |
| Forms | Subcutaneous Injection |
| Common strength | 120 mg |
| Common Indian brands | Enspryng |
| Prescription status | Prescription |
What Satralizumab is used for
Satralizumab is a medicine specifically used in the field of Neuro-Ophthalmology. It is prescribed for the treatment of a condition called Neuromyelitis Optica Spectrum Disorder (NMOSD).
- Neuromyelitis Optica Spectrum Disorder (NMOSD)
NMOSD is a rare, lifelong autoimmune disease that primarily affects the optic nerves (which carry visual information from your eyes to your brain) and the spinal cord. It can lead to symptoms such as vision loss, pain, muscle weakness, and paralysis. Satralizumab helps manage this condition.
How it works
Satralizumab works by targeting and blocking the Interleukin-6 (IL-6) receptor. IL-6 is a protein in the body that plays a key role in inflammation and the immune system. In conditions like NMOSD, IL-6 signalling is thought to drive the relapses or flare-ups of the disease.
By blocking the IL-6 receptor, Satralizumab helps to reduce this signalling, thereby aiming to prevent or reduce the frequency and severity of NMOSD relapses. This mechanism helps to protect the optic nerves and spinal cord from further damage caused by the disease.
How it’s used
Satralizumab is administered as a subcutaneous injection, which means it is given under the skin. The strength available is 120 mg.
For maintenance treatment, the typical dosing schedule is once every 4 weeks. Your ophthalmologist or healthcare provider will provide specific instructions on how and when to administer the injection. It is crucial to follow their directions precisely to ensure the medicine works effectively and safely.
Do not change your dose or stop using Satralizumab without consulting your doctor. They will guide you on the proper technique for administration, which may include training on self-injection if deemed appropriate and safe for you.
Always follow your ophthalmologist’s exact instructions.
Brands available in India
- Enspryng
Brand availability and pricing vary; confirm with your pharmacist.
Good to know
Prescription eye medicine — use only as directed by a qualified ophthalmologist. This page is for general education and is not a substitute for professional medical advice, diagnosis or a prescription. Do not self-medicate or reuse an old prescription.
Precautions & side effects
Satralizumab is a prescription medicine and must only be used under the guidance of a qualified ophthalmologist or a specialist experienced in treating NMOSD. It is not suitable for self-medication.
- Specialist Use: This medicine requires specialist supervision due to the nature of the condition it treats and its mechanism of action.
- Prescription Only: Always use Satralizumab exactly as prescribed by your doctor. Do not share your medicine with others or use it for conditions other than what it was prescribed for.
- Monitoring: Your doctor will likely monitor you regularly while you are on Satralizumab to check for its effectiveness and any potential side effects.
- General Warning: Prescription eye medicine — use only as directed by a qualified ophthalmologist. This page is for general education and is not a substitute for professional medical advice, diagnosis or a prescription. Do not self-medicate or reuse an old prescription.
Understanding Neuromyelitis Optica Spectrum Disorder (NMOSD)
Neuromyelitis Optica Spectrum Disorder (NMOSD) is a rare and serious autoimmune condition that primarily affects the central nervous system, specifically the optic nerves and the spinal cord. In simpler terms, your body’s immune system, which is supposed to protect you from illness, mistakenly attacks healthy cells in these vital areas. This attack can lead to inflammation and damage, causing a range of symptoms.
When the optic nerves are affected, it can lead to vision problems, including blurred vision, pain in the eye, and even significant vision loss in one or both eyes. If the spinal cord is affected, symptoms can include muscle weakness, numbness, tingling, problems with bladder and bowel control, and even paralysis in parts of the body. NMOSD is characterised by unpredictable relapses or flare-ups, where symptoms worsen or new symptoms appear, followed by periods of remission. Early diagnosis and ongoing management are crucial to help control the disease and prevent further damage.
Living with NMOSD can be challenging, but medicines like Satralizumab are designed to help manage the condition by reducing the frequency and severity of these relapses, thereby improving the quality of life for patients. Your doctor will work closely with you to develop a comprehensive treatment plan tailored to your specific needs.
General Advice for Using Injections and Maintaining Hygiene
While Satralizumab is an injection and not an eye drop, maintaining good hygiene is paramount when dealing with any medication, especially those administered by injection. Always wash your hands thoroughly with soap and water before handling the injection or preparing for administration. This helps prevent the introduction of germs and reduces the risk of infection at the injection site. Ensure the injection site is clean and dry as instructed by your healthcare provider.
Proper storage of your medicine is also very important. Always store Satralizumab exactly as directed on the packaging or by your pharmacist. This usually means keeping it in a cool, dry place, often in the refrigerator, away from direct sunlight and heat. Never use medicine that has expired or appears to be damaged or discoloured. Dispose of used needles and syringes safely in a sharps container, as advised by your healthcare provider, to prevent accidental injuries.
When to Seek Medical Help
It is crucial to stay in regular communication with your ophthalmologist or healthcare team while undergoing treatment for NMOSD. If you experience any new or worsening symptoms, or if you notice any unusual reactions after taking Satralizumab, contact your doctor immediately. This includes any signs of infection at the injection site, such as redness, swelling, pain, or pus. Also, report any unexpected side effects or changes in your overall health.
Do not hesitate to ask questions if you are unsure about any aspect of your treatment. Your doctor is your best resource for understanding your condition and how your medicine works. Remember, this page provides general information and is not a substitute for personalised medical advice. Always follow the specific instructions and recommendations provided by your qualified ophthalmologist or healthcare specialist for your care.
Frequently asked questions
What is Satralizumab used for?
Satralizumab is a prescription medicine used to treat Neuromyelitis Optica Spectrum Disorder (NMOSD), a condition that affects the optic nerves and spinal cord.
How does Satralizumab work?
Satralizumab works by blocking the Interleukin-6 (IL-6) receptor, which helps to reduce the signalling that drives NMOSD relapses, thereby preventing or reducing flare-ups of the disease.
What are the common Indian brands for Satralizumab?
In India, Satralizumab is available under the brand name Enspryng.
How is Satralizumab administered?
Satralizumab is given as a subcutaneous injection (under the skin). For maintenance, it is typically administered every 4 weeks.
Do I need a prescription for Satralizumab?
Yes, Satralizumab is a prescription-only medicine and must be used only as directed by a qualified ophthalmologist or specialist.
What are the key precautions to take with Satralizumab?
Satralizumab requires specialist use and should only be administered under the guidance of a qualified ophthalmologist. Always use it exactly as prescribed and do not self-medicate. Regular monitoring by your doctor is also important.
References
- Eye health – MedlinePlus (US National Library of Medicine)
- Eye health information – American Academy of Ophthalmology
- Learn about eye health – National Eye Institute (NIH)
- Blindness and vision impairment – World Health Organization
- StatPearls – NCBI Bookshelf
Medically reviewed by Dr. C Jagadesh Reddy, Chief Surgeon: Cornea, Cataract and Refractive Surgery — last reviewed 2026-07-28.
This page is for general education only and is not a substitute for professional medical advice, diagnosis or treatment. Never self-medicate or reuse an old prescription. Always consult a qualified ophthalmologist before starting, changing or stopping any eye medicine.